ABOUT OCERA

    Company
    Management
    Board of Directors
    Investors
    Scientific Advisors

THERAPEUTIC
FOCUS

CLINICAL
DEVELOPMENT

CLINICAL TRIALS

PARTNERSHIP

NEWS

EVENTS

About Ocera | Investors

Since its inception in 2005, the company has raised a total of $62 million.  Series A was co-led by Domain Associates, L.L.C. and Thomas McNerney & Partners for $14.5 million in 2005, Series B led by Sofinnova Ventures for $12 million in 2006, and the company raised $35.5 million in Series C led by Montagu Newhall Associates in 2008. 


Investors:

Domain Associates, L.L.C. (www.domainvc.com)

Thomas McNerney & Partners (www.tm-partners.com)

Sofinnova Ventures (www.sofinnova.com)

Montagu Newhall Associates (www.montagunewhall.com)

Cross Creek Capital/Wasatch Advisors (www.crosscreekcapital.com)

InterWest Partners (www.interwest.com)

Agechem Venture Fund L.P. (www.agechem.ca)

CDIB BioScience Venture Management (www.cdibbiosciencevc.com)

FinTech GIMV Fund L.P. (http://www.fgi.co.jp/english/index.html)